Derchain SF - Search Results

1

VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients.

Camerin GR, Brito AB, Vassallo J, Derchain SF, Lima CS. Camerin GR, et al. Among authors: derchain sf. Future Oncol. 2017 Feb;13(5):409-414. doi: 10.2217/fon-2016-0299. Epub 2016 Oct 26. Future Oncol. 2017. PMID: 27780361

2

High risk HPV and p53 protein expression in cervical intraepithelial neoplasia.

Vassallo J, Derchain SF, Pinto GA, Martinez EZ, Syrjänen KJ, Andrade LA. Vassallo J, et al. Among authors: derchain sf. Int J Gynaecol Obstet. 2000 Oct;71(1):45-8. doi: 10.1016/s0020-7292(00)00248-4. Int J Gynaecol Obstet. 2000. PMID: 11044541

3

Expression of p16 and cervical infection with high-risk human papillomavirus are not related to p53 activity in cervical intraepithelial neoplasia.

Bragança JF, Sarian LO, Pitta DR, Maito AB, Vassallo J, Pignataro F, Andrade LA, Derchain S. Bragança JF, et al. Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1060-4. doi: 10.1111/j.1525-1438.2007.01148.x. Epub 2007 Nov 16. Int J Gynecol Cancer. 2008. PMID: 18021213

4

Polymorphisms of glutathione S-transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) genes and epithelial ovarian cancer risk.

Oliveira C, Lourenço GJ, Sagarra RA, Derchain SF, Segalla JG, Lima CS. Oliveira C, et al. Among authors: derchain sf. Dis Markers. 2012;33(3):155-9. doi: 10.1155/2012/497692. Dis Markers. 2012. PMID: 22960333 Free PMC article.

5

Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status.

Sallum LF, Sarian LO, Lucci De Angelo Andrade L, Vassallo J, Soares FA, Pinto GA, Ferreira PA, Derchain S. Sallum LF, et al. J Gynecol Oncol. 2013 Apr;24(2):167-76. doi: 10.3802/jgo.2013.24.2.167. Epub 2013 Apr 5. J Gynecol Oncol. 2013. PMID: 23653835 Free PMC article.

6

Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer.

Rinck-Junior JA, Oliveira C, Lourenço GJ, Sagarra RA, Derchain SF, Segalla JG, Lima CS. Rinck-Junior JA, et al. Among authors: derchain sf. J Cancer Res Clin Oncol. 2015 Jan;141(1):69-73. doi: 10.1007/s00432-014-1786-0. Epub 2014 Aug 5. J Cancer Res Clin Oncol. 2015. PMID: 25092217

7

[The new classification of breast cancers: finding the luminal A].

Serra KP, Ramalho S, Torresan R, Vassallo J, Sarian LO, Silva GR, Derchain S. Serra KP, et al. Rev Bras Ginecol Obstet. 2014 Dec;36(12):575-80. doi: 10.1590/so100-720320140005158. Rev Bras Ginecol Obstet. 2014. PMID: 25466817 Portuguese.

8

Cyclooxygenase-2 (COX2) and p53 protein expression are interdependent in breast cancer but not associated with clinico-pathological surrogate subtypes, tumor aggressiveness and patient survival.

Serra KP, Peres RM, Sarian LO, Vassallo J, Pinto GA, Silva GR, Soares FA, da Cunha IW, Espinola J, Bento AM, Del Corso LM, Derchain S. Serra KP, et al. Acta Histochem. 2016 Mar;118(2):176-82. doi: 10.1016/j.acthis.2015.12.009. Epub 2016 Jan 11. Acta Histochem. 2016. PMID: 26791786

9

Preoperative measurement of serum C-reactive protein: is it useful in the differential diagnosis of adnexal masses?

Yoshida A, Derchain SF, Pitta DR, Crozatti N, Andrade LALA, da Silva RF, Sarian LO. Yoshida A, et al. Among authors: derchain sf. Int J Biol Markers. 2017 Mar 2;32(1):e83-e89. doi: 10.5301/jbm.5000226. Int J Biol Markers. 2017. PMID: 27516000 Free article.

10

Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.

Carron J, Brito AB, Torelli AC, Oliveira C, Derchain SF, Lima CS, Lourenço GJ. Carron J, et al. Among authors: derchain sf. Med Oncol. 2016 Oct;33(10):112. doi: 10.1007/s12032-016-0819-8. Epub 2016 Sep 1. Med Oncol. 2016. PMID: 27586145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page